Treatment with LMWHs inhibits factor VIIa generation during in vitro coagulation of whole blood

Thrombosis Research

Volumn 81, Issue 4, 1996, Pages 491-496

  Gerotziafas, G T ^a   Bara, L ^b   Bloch, M F ^b   Makris, P E ^c   Samama, M M ^a  

^a HÔTEL DIEU   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

factor VII; factor VII activation; factor VIIa; LMWH; UFH

Indexed keywords

BLOOD CLOTTING FACTOR 7A; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VEIN THROMBOSIS;

EID: 0029873917     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00022-9     Document Type: Article

References (12)

1. LEIZOROVICZ, A., HAUGH, M.C., CHAPUIS, F.R., SAMAMA, M.M., BOISSEL, J.P. Low molecular weight heparin in prevention of perioperative thrombosis. Br. Med J. 305, 913-920, 1992.
2. NURMOHAMED, M.T., ROSENDAAL, F.R., BULLER, H.R., DEKKER, E., HOMMES, D.W., VANDENBROUKE, J.P. and BRIET, E. Low-molecular-weight heparin versus standard heparin in general and orthopedic surgery : a meta-analysis. Lancet 340, 152-156, 1992.
3. JORGENSEN, L.,N., WILLE-JORGENSEN, P., HAUCH, O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br. J. Surg. 80, 689-704, 1993.
4. LOKNER, D. Low-Molecular-Weight Heparins for treatment of established venous thromboembolism. Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic diseases. Editor Henri Bounameaux, 283-305, Marcel Dekker, Inc.,NYork 1993.
5. ABILDGAARD, U. Heparin/Low Molecular Weight Heparin and tissue factor pathway inhibitor. Haemostasis 23 (suppl 1), 103-106, 1993.
6. WILDGOOSE, P., NEMERSON, Y., HANSEN, L.L., NIELSEN, F.E., GLAZER, S. and HEDNER, U. Measurement of basal levels of factor VIIa in Hemophilia A and B Patients. Blood 80-1, 25-28, 1992.
7. CAEN, J., LARRIEU, M.-J., SAMAMA, M. L'hémostase. Méthodes d'exploration et diagnostic pratique. Editeur : L'EXPANSION SCIENTIFIQUE, Paris, 1968.
8. HUBBARD, AR, BARROWCLIFFE, TW. Measurement of activity Factor VII using soluble mutant Tissue Factor proposal for standardisation. Thrombosis and Haemostasis 72-4, 694-650, 1994.
9. OSTERUD, B. How to measure factor VII and factor VII activation. Haemostasis 13, 161-168, 1983.
10. RAO, L.V.M., RAPAPORT, S.I. and HOANG, A.D. Binding of factor VIIa to tissue factor permits rapid Antithrombin III/Heparin inhibition of factor VIIa. Blood, 81-10, 2600-2607, 1993.
11. OFOSU, F.A., LECLERC, J., DELORME, F., CRAVEN, S., SHAFAI, S. FREWIN, L. and BLAJCHMAN, M.A. The low molecular weight heparin enoxaparin inhibits the consumption of factor VII and prothrombin activation in vivo associated with elective knee replacement surgery. Br. J. Haematol. 82, 391-399, 1992.
12. VALENTIN, S., OSTERGAARD, P., KRISTENSEN, H., NORDFANG, O. Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assays. Blood Coagulation & Fibrinolysis 2 (5), 629-635, 1991.